药品稳定性和储存服务市场，按服务类型、按产品类型、按最终用户、按地理位置

Pharmaceutical Stability And Storage Services Market, By Service Type, By Product Type, By End User, By Geography

出版日期: 2024年03月11日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球药品稳定性和储存服务市场价值为31.8亿美元，预计到2031年将达到47.1亿美元，2024年至2031年的年复合成长率(CAGR)为5.8%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	31.8 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	5.80%	2030/2031 价值预测：	47.1 亿美元

药品稳定性和储存服务市场份额 (%)，按地区，2024 年

过去几年，全球药品稳定性和储存服务市场一直稳定成长。药品需在保质期内保持其功效、安全性和品质。稳定性测试有助于确定药物的有效期，并确保其在核准的保质期内符合所有监管标准。随着时间的推移，温度、湿度和光照等各种因素都会导致药物降解。稳定性测试确定外部影响对药物变质的影响，并产生指定最佳储存条件和有效期所需的资料。它对于开发坚固的包装和最大限度地延长药物的保质期至关重要，并且受到监管机构的强制要求。随着新药的批准和全球仿製药市场的不断增长，对此类服务的需求预计将会增加。

市场动态：

全球药品稳定性和储存服务市场的成长是由药品研发支出不断增加、药品审批严格的监管合规性、仿製药市场不断增长以及相关服务外包需求不断增长等因素推动的。然而，与这些专业测试服务相关的高成本以及全球法规缺乏统一继续限制市场成长。亚太和拉丁美洲等新兴市场为领先的服务提供者扩大其地理覆盖范围提供了有利可图的机会。此外，全球对加速稳定性测试和冷链物流等专业服务的需求不断增长，可能会在不久的将来带来新的机会。

研究的主要特点：

该报告对全球药品稳定性和储存服务市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）介绍了全球药品稳定性和储存服务市场的主要参与者。
本研究涵盖的主要公司包括 Intertek Group plc、Eurofins Scientific、SGS Societe Generale de Surveillance SA.、Q Laboratories、BioLife Solutions Inc.、Cencora, Inc.、Alloga、PCI Pharma Services、Pharmaserv GmbH、Catalent、 Inc、Almac Group 、Charles River Laboratories、Lucideon、Alcami Corporation、Element Materials Technology、Nelson Laboratories, LLC 和ALS。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球药品稳定性和储存服务市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球药品稳定性和储存服务市场的各种策略矩阵轻鬆做出决策。

Intertek Group plc
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
Eurofins Scientific
SGS Societe Generale de Surveillance SA.
Q Laboratories
BioLife Solutions Inc.
Cencora, Inc.
Alloga
PCI Pharma Services
Pharmaserv GmbH
Catalent, Inc
Almac Group
Charles River Laboratories
Lucideon
Alcami Corporation
Element Materials Technology
Nelson Laboratories, LLC
ALS

第 9 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6743

Global pharmaceutical stability and storage services market is estimated to be valued at USD 3.18 Bn in 2024 and is expected to reach USD 4.71 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 3.18 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	5.80%	2030/2031 Value Projection:	US$ 4.71 Bn

Pharmaceutical Stability And Storage Services Market Share (%), By Region, 2024

Pharmaceutical Stability And Storage Services Market - IMG1

Global pharmaceutical stability and storage services market has been growing steadily over the past few years. Pharmaceutical products need to maintain their efficacy, safety, and quality over their shelf life. Stability testing helps to determine a drug's expiration date and ensures it meets all regulatory standards throughout its approved shelf life. Various factors like temperature, humidity, and light exposure can degrade pharmaceuticals over time. Stability testing determines the impact of external influences on drug deterioration and generates the data required to assign optimal storage conditions and expiration dates. It is crucial for developing robust packaging and maximizing a drug's shelf life and is mandated by regulatory bodies. The demand for such services is expected to increase with novel drug approvals and growing generics market worldwide.

Market Dynamics:

Global pharmaceutical stability and storage services market growth is driven by factors such as rising pharmaceutical R&D expenditure, stringent regulatory compliance for drug approval, increasing generics market, and growing demand for outsourcing of related services. However, high costs associated with these specialized testing services and lack of harmonization in global regulations continue to restrain the market growth. Emerging markets such as the Asia Pacific and Latin America offer lucrative opportunities for leading service providers to expand their geographic footprint. Furthermore, increasing demand for specialized services like accelerated stability testing and cold chain logistics worldwide will likely open up new opportunities in the near future.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmaceutical stability and storage services market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pharmaceutical stability and storage services market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Intertek Group plc, Eurofins Scientific, SGS Societe Generale de Surveillance SA., Q Laboratories, BioLife Solutions Inc., Cencora, Inc., Alloga, PCI Pharma Services, Pharmaserv GmbH, Catalent, Inc, Almac Group, Charles River Laboratories, Lucideon, Alcami Corporation, Element Materials Technology, Nelson Laboratories, LLC, and ALS.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global pharmaceutical stability and storage services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical stability and storage services market.

Detailed Segmentation:

Service Type:
- Stability
- Accelerated Stability Testing
- Photostability
- Long Term Drug Stability Testing
- Forced Degradation Testing
- Others
- Storage
- Cold Storage
- Controlled 15-25°C
- Refrigerated 2-8°C
- Frozen -24°C
- Cryogenic -170°C
- Non - Cold Storage
Product Type:
- Tablets
- Capsules
- Injectable Solutions
- Oral Suspensions
- Combination Products
- Others
End User:
- Biopharmaceutical Companies
- CMO
- CRO
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Intertek Group plc
- Eurofins Scientific
- SGS Societe Generale de Surveillance SA.
- Q Laboratories
- BioLife Solutions Inc.
- Cencora, Inc.
- Alloga
- PCI Pharma Services
- Pharmaserv GmbH
- Catalent, Inc
- Almac Group
- Charles River Laboratories
- Lucideon
- Alcami Corporation
- Element Materials Technology
- Nelson Laboratories, LLC
- ALS

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Company Market Share Analysis
Regulatory Scenario
COVID-19 Impact Analysis
Healthcare Spending by Country
Number of Service Providers

4. Global Pharmaceutical Stability and Storage Services Market, By Service Type, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Stability, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Accelerated Stability Testing, 2019 - 2031 (US$ Billion)
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Photostability, 2019 - 2031 (US$ Billion)
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Long Term Drug Stability Testing, 2019 - 2031 (US$ Billion)
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Forced Degradation Testing, 2019 - 2031 (US$ Billion)
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031 (US$ Billion)
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Storage, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Cold Storage, 2019 - 2031 (US$ Billion)
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Controlled 15-25°C
Refrigerated 2-8°C
Frozen -24°C
Cryogenic -170°C
Non - Cold Storage, 2019 - 2031 (US$ Billion)
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Pharmaceutical Stability and Storage Services Market, By Product Type, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Tablets, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Capsules, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Injectable Solutions, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Oral Suspensions, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Combination Products, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Pharmaceutical Stability and Storage Services Market, By End User, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Biopharmaceutical Companies, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CMO, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CRO, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others , 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Pharmaceutical Stability and Storage Services Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

8. Company Profiles - Global Pharmaceutical Stability and Storage Services Market

Intertek Group plc
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Eurofins Scientific
SGS Societe Generale de Surveillance SA.
Q Laboratories
BioLife Solutions Inc.
Cencora, Inc.
Alloga
PCI Pharma Services
Pharmaserv GmbH
Catalent, Inc
Almac Group
Charles River Laboratories
Lucideon
Alcami Corporation
Element Materials Technology
Nelson Laboratories, LLC
ALS